{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJvK3s8KDA","founded_year":1991,"lastupdate":"2022-11-22T00:00:00.000Z","update_date":"2022-11-22T00:00:00.000Z","lastModified":"Oct 27, 2021","confidence_score":59,"active":1,"confidence_score_reason":"product stage, sector, tags, business model, video or image, funding rounds, markets, not claimed","urlname":"advanced-medical-solutions-group","minimal_profile":null,"status":"Public","fullstatus":"Public on LSE on Nov, 1998;","acquired":0,"description_edited":0,"tag_line_edited":0,"phone":"","registrar":"","biverification":"Jenny Sotnik-Talisman","recentupdates":[{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-01-25 07:57:56.000000","last_name":"Levin","first_name":"Eran"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-08-25 15:31:49.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-08-07 05:46:20.000000","last_name":"Levin","first_name":"Eran"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-08-07 05:09:36.000000","last_name":"Levin","first_name":"Eran"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-05 15:10:40.000000","last_name":"Levin","first_name":"Eran"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-22 06:25:28.000000","last_name":"Levin","first_name":"Eran"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-11-22 17:56:12.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-11-22 17:56:12.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-01-25 07:57:56.000000","last_name":"Levin","first_name":"Eran"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-11-22 17:57:02.000000","last_name":"Perlov","first_name":"Maor"},{"email":"santi.kesel@gmail.com","source":"Manual","datetime":"2021-10-26 07:10:58.000000","last_name":"Kesel","first_name":"Santiago"},{"email":"santi.kesel@gmail.com","source":"Manual","datetime":"2021-10-27 10:24:04.000000","last_name":"Kesel","first_name":"Santiago"},{"email":"santi.kesel@gmail.com","source":"Manual","datetime":"2021-10-27 10:19:56.000000","last_name":"Kesel","first_name":"Santiago"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:26:57.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:33:10.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:28:53.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:28:53.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:33:25.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:35:21.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:35:21.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:40:19.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:40:19.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:55:53.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:41:30.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:41:30.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:41:30.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:47:55.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:37:17.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:37:17.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:38:12.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:38:12.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:31:56.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:55:39.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:55:43.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:49:52.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:25:45.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:31:01.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:26:47.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:26:47.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:26:47.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:26:47.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:27:18.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:47:41.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:47:41.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:47:41.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:35:48.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:35:48.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 07:46:13.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:29:48.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:34:35.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:34:35.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 07:45:34.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 07:45:34.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 07:45:34.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 07:45:34.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 07:45:34.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 07:45:34.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 07:45:34.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"yamila.urwicz@gmail.com","source":"Manual","datetime":"2019-02-03 12:48:03.000000","last_name":"Silbert","first_name":"Yamila"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2019-04-10 06:03:11.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2019-04-10 06:03:11.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2019-04-10 06:03:11.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2019-04-10 06:03:11.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2019-08-25 15:01:49.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2019-11-25 14:01:55.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2019-05-27 13:11:39.000000","last_name":"Perlov","first_name":"Maor"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2019-04-10 06:03:27.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-08-25 15:31:49.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-08-25 15:31:55.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-08-25 15:32:01.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-08-25 15:31:49.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-05 14:23:26.000000","last_name":"Levin","first_name":"Eran"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-03-20 06:37:34.000000","last_name":"Levin","first_name":"Eran"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-05 14:42:29.000000","last_name":"Levin","first_name":"Eran"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-01-25 16:18:39.000000","last_name":"Levin","first_name":"Eran"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-02-13 06:58:16.000000","last_name":"Levin","first_name":"Eran"}],"sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2019-11-25T00:00:00.000Z","crunchbaseid":"advanced-medical-solutions","lastupdator":"Maor Perlov","lastupdator_email":"maor.perlov@sncentral.org","creator":"Yamila Silbert","creator_email":"yamila.urwicz@gmail.com","createdate":"2019-02-03T00:00:00.000Z","lastupdatedate":"2022-11-22","hide_reason":null,"hide_reason_data":null,"logokey":"$j9mxARzKFV5aG4G3bUQxg5D4JfQEomx4eJBxFpTPxN4Lmk9xGF0JRe","name":"Advanced Medical Solutions Group","israeliacquisitions":1,"forbesranking":null,"investmentarm":null,"investmentarmname":null,"hubname":null,"acquired_amount":null,"acquired_by":null,"acquired_country":null,"acquired_month":null,"acquired_year":null,"type":"Multinational","formernames":[],"alternativenames":["Advanced Medical Solutions","AMS Group"],"country":"United Kingdom","inisraelsince":"2/2019","inisraelsincemonth":"2","isisraeli":0,"marketcapital":611428340,"marketcapitaldate":"2025-11-01T14:07:41.000Z","oneliner":"Medical Devices and Equipment and Supplies","website":"https://www.admedsol.com","employees":"11-50","employees_exact":12,"employees_overall":"1-500","employees_overall_exact":444,"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/563418","instagram":""},"social":["https://www.linkedin.com/company/563418"],"flattenedsociallinks":"https://www.linkedin.com/company/563418","apps":{"appstore":"","googleplay":""},"investmentstage":[],"about":"Advanced Medical Solutions (AMS) Group plc designs, develops and produces novel high performance polymers, both natural and synthetic, for the healthcare market. The company's products include wound care products and non-wound care products such as biomaterials, tubing products, textiles and dipped products.\r\n\r\nAMS acquired the Israeli company Sealantis in 2019, a developer of protein-free tissue adhesives based on proprietary alga-mimetic formulations to be used in a wide range of surgical applications. The Israeli R&D people is joining the AMS' surgical R&D capability.\r\n\r\n","founded":"1/1991","team":[{"name":"Tomer Fuchs","email":"tomer@admedsol.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkPCcspgLDA","bounced":true,"claimed":0,"founder":0,"urlname":"tomer-fuchs-3","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQiIXMmgoM","position":"Corporate BD, Licensing and Aquisitions Director ","last_name":"Fuchs","claimtoken":"2y3CVibLq7xtIfQfUcMy5TSA6mGd29vlMBXydXt5GZgsFaO20YDZj0","first_name":"Tomer","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/tomer-fuchs-21557814/","unsubscribed":false,"is_activeuser":1,"additionalemail":"tomer.fuchs@admedsol.com","claimedemaildate":"2022-11-22 17:57:15.000000","initials":"TF","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ohad Kimhi","email":"ohadk@sealantis.co.il","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoJuxoKYIDA","bounced":true,"claimed":0,"founder":0,"urlname":"ohad-kimhi","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgq6jA9AsM","position":"Director R&D","last_name":"Kimhi","claimtoken":"d11bc53ce85b03c432f48d5423b425235ab22380c6b00f309be4620d65d3348b","first_name":"Ohad","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ohad-k-91928816","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"OK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"portfolio":[{"name":"Sealantis","hidden":false,"raised":"Undisclosed","founded":"2007","fullurl":"/company_page/sealantis","logokey":"$J0oQ2WV9GD5NjHFK6aBT1Lz1isXJSajiSLXvYsVdD2pHin53ie6IOz","urlname":"sealantis","employees":"11-50","company_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN75svkLDA","description":"Alga-mimetic Tissue Adhesives","fundingstage":"Acquired","businessmodel":"B2B","raisedNumber":0,"logourl":"https://storage.googleapis.com/clean-finder-353810/$J0oQ2WV9GD5NjHFK6aBT1Lz1isXJSajiSLXvYsVdD2pHin53ie6IOz","style":"","hiddenCompanyTooltip":""}],"exits":[],"mediagallery":[],"affiliatedOrganizations":null,"address":{"israeli":[{"id":"7a63c65d-9850-436e-a137-493754bd9d80","city":"Haifa","type":["R&D"],"address":"Haifa, Israel","placeid":null,"notactive":0,"openeddate":"2019-02-01","registrarid":"514346295","firstrdcenter":0,"registrarname":"advanced medical solutions israel (sealantis)"}],"officesabroad":[{"id":"No6th4rPS5t5WO1ZzYtHKpZQ6S1SCWlsMnF0BL1lSoU1B2GS1ue6e5","city":"Winsford","address":"Winsford CW7, UK","country":"United Kingdom","placeid":null}]},"headquarter_address":"Road One, Winsford CW7, UK","news":[{"id":"WAKMcaWRwcqJSODMwpS5lW9Nm96Rs8wuFiZ3UCafuSGRk12QIN2uWH","date":"Oct 20, 2025","link":"https://finance.yahoo.com/news/3-uk-stocks-may-undervalued-063754019.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":["undervalued","growth"],"round":null,"company":"Nichols plc","layoffs":null,"summary":"Nichols plc, a company with a market cap of £396.78 million, supplies soft drinks to various industries globally. The company is trading at a 41.9% discount to its estimated fair value, suggesting it is significantly undervalued. Despite a slight dip in recent earnings, Nichols forecasts robust annual profit growth of 16.4%, surpassing the UK market average. Analysts predict a potential stock price increase of 34.8%. However, the company has an unstable dividend track record, and recent executive changes could affect future performance stability. Overall, Nichols is poised for substantial financial growth, making it an attractive option for investors seeking undervalued stocks.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["undervalued stocks","market analysis","profit growth","dividend stability","executive changes"],"date_of_event":"October 2025","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"cBm4Pu0Bb9lE7fkIRvIzkn7jwSgeMkSUwfOLR4sbT7f8FhXdgklqfU","news_summary":"3 UK Stocks That May Be Undervalued In October 2025","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"XPqdTH19qXo3Q2EsIM5o845fwwZbB2dnS7WDoRyzRVvWYbkzSILo2k","date":"Sep 9, 2025","link":"https://finance.yahoo.com/news/taylor-wimpey-lse-tw-fresh-125045039.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"valuation, market sentiment","round":null,"company":"Taylor Wimpey","layoffs":null,"summary":"Taylor Wimpey has experienced a 33% decline in share value over the past year, despite showing growth in annual revenue and net income. The market seems to undervalue the company based on analysts expectations of improved growth and operating margins in the future. However, persistent affordability issues and rising build costs pose risks to this optimistic outlook. The company is seen as undervalued with a fair value of £1.32, but market comparisons suggest it might be more expensive than it appears. The article discusses the potential for future growth and the challenges that might hinder it.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["valuation","growth","market sentiment","profitability","affordability"],"date_of_event":null,"product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":"£1.32","impact_on_company":"growth-negative","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"SN7XBgsqV1gjO2H8InDshAn154po4nh0lsozhDt1WFXzB7weYlVedL","news_summary":"Taylor Wimpey (LSE:TW.): A Fresh Look at Valuation After a Year of Share Price Pressure","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"lvIMbjnAjbSGheb1D9QqiHm9P2s9Ag28tHTESu5HAN4VAiOnzoZcJb","date":"Sep 9, 2025","link":"https://finance.yahoo.com/news/form-8-3-unite-group-103600449.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"securities disclosure","round":null,"company":"UNITE GROUP PLC","layoffs":null,"summary":"The article is a public disclosure under Rule 8.3 of the Takeover Code, detailing the positions and dealings of Massachusetts Financial Services Company in the securities of UNITE GROUP PLC. The disclosure reveals that Massachusetts Financial Services Company holds 1.89% of UNITE GROUP PLCs ordinary shares, amounting to 9,240,894 shares. Additionally, the company sold 2,334 shares at a price of 7.0735 GBP per unit. The disclosure is part of regulatory requirements for transparency in securities dealings, especially in the context of potential takeovers.","partners":null,"customers":null,"eventType":null,"investors":"Massachusetts Financial Services Company","confidence":9,"key_topics":["securities","disclosure","financial","positions","derivatives"],"date_of_event":"09 September 2025","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"M8aM7PcmNvtzfSqAnJNivz2u0eILbvVQAFY8PP9ww9f2rf7KLUYvIC","news_summary":"Form 8.3 - UNITE GROUP PLC","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"MH3vZoJW86CsPlQp5H4b7tKc8AYASJOt7rE2kbnSG8mOSUlYrHCCUR","date":"Sep 9, 2025","link":"https://finance.yahoo.com/news/hsbc-holdings-plc-announces-results-105200726.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"debt-reduction","round":null,"company":"HSBC Holdings plc","layoffs":null,"summary":"HSBC Holdings plc announced the results of its offers to purchase for cash any and all of the outstanding series of subordinated notes. The offers, which expired on September 8, 2025, resulted in the acceptance of $509,753,000 in principal amount of notes across four series, with a total consideration of $580,014,257.48. This move is part of HSBCs strategy to manage its debt portfolio. The offers were made under the terms set forth in the Offer to Purchase dated September 2, 2025. The notes tendered are subject to guaranteed delivery procedures, with a deadline of September 10, 2025. This action reflects HSBCs ongoing efforts to optimize its financial structure.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["debt","notes","purchase","offers","consideration"],"date_of_event":"September 8, 2025","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"bKSNgmFLzgmlWshQ1L8g4mn48yNOwvoZvJjObwrW6og6Qa11cvOalD","news_summary":"HSBC HOLDINGS PLC ANNOUNCES RESULTS OF ITS TENDER OFFERS FOR FOUR SERIES OF NOTES","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"054f15aa-5e43-408e-b535-f44690d7f1e6","date":"Jan 31, 2019","link":"https://globenewswire.com/news-release/2019/01/31/1708222/0/en/Advanced-Medical-Solutions-Group-plc-Acquisition-of-Sealantis.html","source":"globenewswire.com","visible":1,"analysis":{"tags":"acquisition","company":"Advanced Medical Solutions Group plc","layoffs":null,"summary":"Advanced Medical Solutions Group plc has acquired Sealantis, an Israeli-based medical device company, for $US 25m in cash. The acquisition provides AMS with a technology platform and delivery systems that have significant potential in the internal surgery market, particularly in the $1 billion internal sealant market. Sealantis has developed an alginate-based tissue adhesive technology platform with multiple surgical sealant products under development. The acquisition is expected to be earnings dilutive until product sales commence in H1 2021. AMS plans to invest approximately £8m in R&D, regulatory, and clinical costs over the next three years. The company aims to maximize the value of the investment by running clinical trials and obtaining approval for new indications. Sealantis innovation team of R&D experts will become part of AMSs surgical R&D capability.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Acquisition","Technology","Internal surgery market","Sealantis","Product development"],"date_of_event":"January 31, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition","Expand"],"acquisition_amount":"$US 25m","structuredIssuesShow":"#Acquisition  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"jgeh4EKbE0cWFKSnv73CXib9sQhYLEn1In8rRCrMttIxY2QG4eC48b","news_summary":"Advanced Medical Solutions Group plc: Acquisition of Sealantis","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"extensions":null,"events":null,"hide_reasons":[{"id":"75T5aG1f0dpqYFonup40lXNjO046zUH82TaHW1TAiIMf9aYAsSOl0d","reason":"No relevant activity"},{"id":"7KVi9S7qqUtO0WCsFclwqBEZluejfNYqWC1Uhx0tPHtDxtvxPPaCPH","reason":"No longer active"},{"id":"hoyKAmu4YJEHmhtLwCdeFldSnDwaVbPXOnH0RA9hKHCzAcHO6OOrXd","reason":"Pending approval"},{"id":"TC54H7CXyKO8GmPECkbyKJf8n34r70JlfJTJHfo85exRpLaKI1Efs9","reason":"Pending approval - External entity"}],"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCwpvibCAw","hub":null,"date":"1998-11-20","batch":"","token":"","amount":null,"hub_id":null,"source":"","ticker":"AMS","enddate":"","mnatype":null,"eventtype":"POEvent","granttype":null,"valuation":null,"investment":[],"hub_logokey":null,"hub_urlname":null,"wasacquired":null,"delistreason":null,"capitalraised":null,"stockexchange":"LSE","eventvisibility":"Public","amountvisibility":null,"duetoacquisition":null,"isextensionround":null,"token_visibility":"","fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCozKWUCQw","acquiredcompany_mna":null,"communitycompany_id":null,"isjointventuregrant":null,"acquiredcompany_spac":"Undisclosed","communitycompany_name":null,"communitycompany_type":null,"stockexchange_logokey":"$E83RXxMVGwp7cm0L2Z0i2ni1EON0UyaH6ehVTD4KOSAdnkUnZNQ7wV","acquiredcompany_mna_id":null,"fundingtypefundingtype":null,"acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"communitycompany_hidden":null,"communitycompany_fullurl":null,"communitycompany_logokey":null,"communitycompany_urlname":null,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_logokey":null,"acquiredcompany_mna_urlname":null,"acquiredcompany_mna_homepage":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_homepage":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"acquiredcompany_reverse_homepage":null,"hub_logourl":"/assets/empty-state.svg","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$E83RXxMVGwp7cm0L2Z0i2ni1EON0UyaH6ehVTD4KOSAdnkUnZNQ7wV","communitycompany_logourl":"/assets/empty-state.svg","acquiredcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","style":"","hiddenCompanyTooltip":""}],"techcommunityinvolvement":null,"tags":[],"investments":[],"funds":[],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"1-500","fundingtype":"Multinational","parsedName":"Advanced Medical Solutions Group","logourl":"https://storage.googleapis.com/clean-finder-353810/$j9mxARzKFV5aG4G3bUQxg5D4JfQEomx4eJBxFpTPxN4Lmk9xGF0JRe","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$j9mxARzKFV5aG4G3bUQxg5D4JfQEomx4eJBxFpTPxN4Lmk9xGF0JRe","teamMembersNumber":2,"nationality":"Foreign","communityinvolvement":[],"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}